A recent decision by the US Supreme Court may lead to increased legal action within the healthcare sector, says one expert. Federal Trade Commission deputy assistant director Sara Razi suggested that the Court’s decision, made last February, strengthened federal antitrust lawyers when clarifying when state antitrust law can trump federal; the Court unanimously agreed that “state-action immunity is disfavored” in FTC vs. Phoebe Putney Health System. The FTC sued the health group over a merger, approved by Georgia’s state hospital regulators. According to Razi, the ruling was “manna from heaven” and suggested that the Court’s ruling demonstrated unity between liberals and conservatives when it comes to federal antitrust exemptions. According to Razi, this may lead to more legal action taken within the healthcare sector as federals find the support of Supreme Court precedence.
Featured News
US Appeals Court Reinstates AI Pricing Antitrust Case Against Atlantic City Casinos
Jul 29, 2026 by
CPI
Democratic Senators Seek SEC Investigation Into Trump Media’s Premium
Jul 29, 2026 by
CPI
Publicis Challenges Naming in India Antitrust Investigation Before Delhi Court
Jul 29, 2026 by
CPI
Appeals Court Revives AI Hotel Pricing Antitrust Lawsuit Against Caesars, MGM
Jul 29, 2026 by
CPI
EU Warns FIFA Commercial Overhaul Could Violate Competition Law
Jul 29, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes